Characteristics and survival of patients with invasive amelanotic melanoma in the USA

Melanoma Research

Volumn 23, Issue 5, 2013, Pages 408-413

  Moreau, Jacqueline F ^b   Weissfeld, Joel L ^a   Ferris, Laura K ^b  

^a GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Aged; Amelanotic melanoma; Disease free survival; Epidemiology; Epidemiology and End Results; Skin neoplasms; Surveillance; USA

Indexed keywords

AGE; AMELANOTIC MELANOMA; ARTICLE; CANCER EPIDEMIOLOGY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MELANOTIC MELANOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX; SKIN ULCER; UNITED STATES; ADOLESCENT; ADULT; AGED; CHI SQUARE DISTRIBUTION; CHILD; EPIDEMIOLOGY; INFANT; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; RISK FACTOR; SEX DIFFERENCE; SKIN TUMOR; TIME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KAPLAN-MEIER ESTIMATE; MALE; MELANOMA, AMELANOTIC; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; SEER PROGRAM; SEX FACTORS; SKIN NEOPLASMS; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84887991556     PISSN: 09608931     EISSN: 14735636     Source Type: Journal    
DOI: 10.1097/CMR.0b013e32836410fe     Document Type: Article

References (38)

1. Huvos AG, Shah JP, Goldsmith HS. A clinicopathologic study of amelanotic melanoma. Surg Gynecol Obstet 1972; 135:917-920.
2. Ariel IM. Malignant melanoma of the upper extremities. J Surg Oncol 1981; 16:125-143.
3. Clark WH Jr, From L, Bernardino EA, Mihm MC. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 1969; 29:705-727.
4. Giuliano AE, Cochran AJ, Morton DL. Melanoma from unknown primary site and amelanotic melanoma. Semin Oncol 1982; 9:442-447.
5. Gualandri L, Betti R, Crosti C. Clinical features of 36 cases of amelanotic melanomas and considerations about the relationship between histologic subtypes and diagnostic delay. J Eur Acad Dermatol Venereol 2009; 23:283-287.
6. Abdulla FR, Kerns MJ, Mutasim DF. Amelanotic lentigo maligna: a report of three cases and review of the literature. J Am Acad Dermatol 2010; 62:857-860.
7. Allan SJ, Dicker AJ, Tidman MJ, McLaren KM, Hunter JA. Amelanotic lentigo maligna and amelanotic lentigo maligna melanoma: a report of three cases mimicking intraepidermal squamous carcinoma. J Eur Acad Dermatol Venereol 1998; 11:78-81.
8. Cliff S, Otter M, Holden CA. Amelanotic lentigo maligna melanoma of the face: a case report and review of the literature. Clin Exp Dermatol 1997; 22:177-179.
9. Kaufmann R, Nikelski K, Weber L, Sterry W. Amelanotic lentigo maligna melanoma. J Am Acad Dermatol 1995; 32 (2 Pt 2):339-342.
10. Kelly RI, Cook MG, Mortimer PS. Aggressive amelanotic lentigo maligna. Br J Dermatol 1994; 131:562-565.
11. McKenna DB, Cooper EJ, Kavanagh GM, Davie RM, McLaren KM, Tidman MJ. Amelanotic malignant melanoma following cryosurgery for atypical lentigo maligna. Clin Exp Dermatol 2000; 25:600-604.
12. Rocamora V, Puig L, Romaní J, de Moragas JM. Amelanotic lentigo maligna melanoma: report of a case and review of the literature. Cutis 1999; 64: 53-56.
13. Rahbari H, Nabai H, Mehregan AH, Mehregan DA, Mehregan DR, Lipinski J. Amelanotic lentigo maligna melanoma: a diagnostic conundrum-presentation of four new cases. Cancer 1996; 77:2052-2057.
14. Andre J, Moulonguet I, Goettmann-Bonvallot S. In situ amelanotic melanoma of the nail unit mimicking lichen planus: report of 3 cases. Arch Dermatol 2010; 146:418-421.
15. Gosselink CP, Sindone JL, Meadows BJ, Mohammadi A, Rosa M. Amelanotic subungual melanoma: a case report. J Foot Ankle Surg 2009; 48:220-224.
16. Grunwald MH, Yerushalmi J, Glesinger R, Lapid O, Zirkin HJ. Subungual amelanotic melanoma. Cutis 2000; 65:303-304.
17. Hara M, Kato T, Tagami H. Amelanotic acral melanoma masquerading as fibrous histiocytic tumours. Three case reports. Acta Derm Venereol 1993; 73:283-285.
18. Harrington P, O'Kelly A, Trail IA, Freemont AJ. Amelanotic subungual melanoma mimicking pyogenic granuloma in the hand. J R Coll Surg Edinb 2002; 47:638-640.
19. Cheung WL, Patel RR, Leonard A, Firoz B, Meehan SA. Amelanotic melanoma: a detailed morphologic analysis with clinicopathologic correlation of 75 cases. J Cutan Pathol 2012; 39:33-39.
20. Holder JE, Colloby PS, Fletcher A, Camp RD. Amelanotic superficial spreading malignant melanoma mimicking Bowen's disease. Br J Dermatol 1996; 134:519-521.
21. Tschen JA, Fordice DB, Reddick M, Stehlin J. Amelanotic melanoma presenting as inflammatory plaques. J Am Acad Dermatol 1992; 27:464-465.
22. Borkovic SP, Schwartz RA. Amelanotic lentigo maligna melanoma manifesting as a dermatitislike plaque. Arch Dermatol 1983; 119:423-425.
23. House NS, Fedok F, Maloney ME, Helm KF. Malignant melanoma with clinical and histologic features of Merkel cell carcinoma. J Am Acad Dermatol 1994; 31 (5 Pt 2):839-842.
24. SEER Stat Databases. November 2011 submission. Available at: http://seer.cancer.gov/data/seerstat/nov2011/. [Accessed 27 September 2012].
25. SEER Registry Groupings for Analyses. Available at: http://seer.cancer. gov/registries/terms.html. [Accessed 27 September 2012].
26. Fritz A, Ries L. SEER Extent of Disease: 1988 Codes and coding instructions. 3rd edition Collaborative Stage Data Collection System. Coding Instructions v.02-04 Chicago, IL: American Joint Committee on Cancer; 1998. Available at: http://www.cancerstaging.org/cstage/manuals/coding0204.html [Accessed 4 July 2013].
27. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27:6199-6206.
28. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94:496-509.
29. Pizzichetta MA, Talamini R, Stanganelli I, Puddu P, Bono R, Argenziano G, et al. Amelanotic/hypomelanotic melanoma: clinical and dermoscopic features. Br J Dermatol 2004; 150:1117-1124.
30. Piliouras P, Gilmore S, Wurm EM, Soyer HP, Zalaudek I. New insights in naevogenesis: number, distribution and dermoscopic patterns of naevi in the elderly. Australas J Dermatol 2011; 52:254-258.
31. Scoggins CR, Ross MI, Reintgen DS, Noyes RD, Goydos JS, Beitsch PD, et al. Sunbelt Melanoma Trial. Gender-related differences in outcome for melanoma patients. Ann Surg 2006; 243:693-698, discussion 698-700.
32. Austin PF, Cruse CW, Lyman G, Schroer K, Glass F, Reintgen DS. Age as a prognostic factor in the malignant melanoma population. Ann Surg Oncol 1994; 1:487-494.
33. Menzies SW, Kreusch J, Byth K, Pizzichetta MA, Marghoob A, Braun R, et al. Dermoscopic evaluation of amelanotic and hypomelanotic melanoma. Arch Dermatol 2008; 144:1120-1127.
34. Jaimes N, Halpern JA, Puig S, Malvehy J, Myskowski PL, Braun RP, Marghoob AA. Dermoscopy: an aid to the detection of amelanotic cutaneous melanoma metastases. Dermatol Surg 2012; 38:1437-1444.
35. Zalaudek I, Kreusch J, Giacomel J, Ferrara G, Catricalà C, Argenziano G. How to diagnose nonpigmented skin tumors: a review of vascular structures seen with dermoscopy: part I. Melanocytic skin tumors. J Am Acad Dermatol 2010; 63:361-374, quiz 375-376.
36. Shaikh WR, Xiong M, Weinstock MA. The contribution of nodular subtype to melanoma mortality in the United States, 1978 to 2007. Arch Dermatol 2012; 148:30-36.
37. Cockburn M, Swetter SM, Peng D, Keegan TH, Deapen D, Clarke CA. Melanoma underreporting: why does it happen, how big is the problem, and how do we fix it? J Am Acad Dermatol 2008; 59:1081-1085.
38. Swetter SM, Pollitt RA, Johnson TM, Brooks DR, Geller AC. Behavioral determinants of successful early melanoma detection: role of self and physician skin examination. Cancer 2012; 118:3725-3734.